Lipocine
LPCN
LPCN
53 hedge funds and large institutions have $94.3M invested in Lipocine in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% less capital invested
Capital invested by funds: $119M → $94.3M (-$24.5M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
53
Holding in Top 10
1
Calls
$672K
Puts
$272K
Top Buyers
| 1 | +$1.54M | |
| 2 | +$1.01M | |
| 3 | +$681K | |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
+$630K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$555K |
Top Sellers
| 1 | -$1.88M | |
| 2 | -$1.63M | |
| 3 | -$933K | |
| 4 |
VAM
Visium Asset Management
New York
|
-$742K |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
-$389K |